Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090359 · ClinicalTrials.gov registry record · Phase 4
Dual Mobility Acetabular Cups in Revision TJA
A Phase 4 study of Dislocation, Hip, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 322
- Enrollment target
- 2
- Study locations
NCT04090359 is a Phase 4 study of Dislocation, Hip that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 322 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04090359, a Phase 4 study of Dislocation, Hip, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 322 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.
Conditions Studied
Interventions
- DEVICE Dual Mobility Implant
- DEVICE Conventional, single-bearing implant
Study Locations (2)
New York
- New York University Medical Center - New York
Pennsylvania
- Rothman Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2036-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04090359
The ClinicalTrials.gov registry entry for NCT04090359 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dislocation, Hip appearing as the primary indexed condition, and to 2 interventions - of which Dual Mobility Implant is the first listed.
NCT04090359 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04090359 about?
NCT04090359 is a clinical study titled "Dual Mobility Acetabular Cups in Revision TJA". The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in r...
What is the current status of trial NCT04090359?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 322 participants. The study started on 2017-09-01. Estimated completion is 2036-12-01.
What conditions does trial NCT04090359 study?
This clinical trial studies the following conditions: Dislocation, Hip.
What interventions are being tested in trial NCT04090359?
The interventions under investigation include: Dual Mobility Implant (DEVICE), Conventional, single-bearing implant (DEVICE).
Who is sponsoring clinical trial NCT04090359?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04090359 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dislocation, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.